Alteotech Moves Forward With KOSPI Relisting Plan
According to Newsis on July 12, Alteotech, a leading KOSDAQ-listed biopharmaceutical company, is advancing its relisting to KOSPI. The company passed a shareholder resolution in December 2025 to transfer its listing to Korea's main bourse. Alteotech aims to leverage its distinctive drug
GateNews·07-11 23:07
